| Intraventricular hemorrhage and vitamin E in the very low-birth-weight infant: evidence for efficacy of early intramuscular vitamin E administration ME Speer, C Blifeld, AJ Rudolph, P Chadda, MEB Holbein, HM Hittner Pediatrics 74 (6), 1107-1112, 1984 | 131 | 1984 |
| Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients DB Chalfin, MEB Holbein, AM Fein, GC Carlon Jama 269 (2), 249-254, 1993 | 97 | 1993 |
| Retrolental fibroplasia and vitamin E in the preterm infant—comparison of oral versus intramuscular: oral administration HM Hittner, ME Speer, AJ Rudolph, C Blifeld, P Chadda, MEB Holbein, ... Pediatrics 73 (2), 238-249, 1984 | 89 | 1984 |
| Understanding FDA regulatory requirements for investigational new drug applications for sponsor-investigators MEB Holbein Journal of investigative medicine 57 (6), 688-694, 2009 | 88 | 2009 |
| IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis G Szabo, M Mitchell, CJ McClain, S Dasarathy, B Barton, AJ McCullough, ... Hepatology 76 (4), 1058-1068, 2022 | 66 | 2022 |
| Access to investigational drugs: FDA expanded access programs or “right‐to‐try” legislation? MEB Holbein, JP Berglund, K Weatherwax, DE Gerber, JE Adamo Clinical and translational science 8 (5), 526-532, 2015 | 48 | 2015 |
| Exercise-associated collapse in cyclists is unrelated to endotoxemia. GE Moore, ME Holbein, JP Knochel Medicine and science in sports and exercise 27 (9), 1238-1242, 1995 | 41 | 1995 |
| Vitamin E in retrolental fibroplasia IJ Smith, MFG Buchanan, I Goss, PJ Congdon, HM Hittner, FL Kretzer, ... New England Journal of Medicine 309 (11), 669-670, 1983 | 33 | 1983 |
| Count me in: using a patient portal to minimize implicit bias in clinical research recruitment V Kannan, KE Wilkinson, M Varghese, S Lynch-Medick, DL Willett, ... Journal of the American Medical Informatics Association 26 (8-9), 703-713, 2019 | 28 | 2019 |
| Experience, perceptions, and recommendations concerning COVID-19–related clinical research adjustments DE Gerber, TY Sheffield, MS Beg, EL Williams, VL Clark, Y Xie, ... Journal of the National Comprehensive Cancer Network 19 (5), 505-512, 2020 | 22 | 2020 |
| Understanding Food and Drug Administration regulatory requirements for an investigational device exemption for sponsor-investigators MEB Holbein, JP Berglund Journal of Investigative Medicine 60 (7), 987-994, 2012 | 15 | 2012 |
| Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic M Gravelin, J Wright, MEB Holbein, M Berro, JS Brown, GA Mashour, ... Journal of Clinical and Translational Science 5 (1), e94, 2021 | 8 | 2021 |
| Right now, in the right way: US Food and Drug Administration’s expanded access program and patient rights MEB Holbein, KJ Weatherwax, M Gravelin, R Hutchinson, GA Mashour Journal of clinical and translational science 2 (3), 115-117, 2018 | 8 | 2018 |
| Recommendations from the investigational new drug/investigational device exemption task force of the clinical and translational science award consortium: developing and … MEB Holbein, JP Berglund, EK O'Reilly, K Hartman, LA Speicher, ... Journal of Investigative Medicine 62 (5), 797-803, 2014 | 8 | 2014 |
| Longitudinal experience with and impressions of COVID-19–related clinical research changes DE Gerber, VL Clark, TY Sheffield, MS Beg, Y Xie, MEB Holbein, ... JCO Oncology Practice 18 (1), e98-e107, 2022 | 7 | 2022 |
| Warning Letters to Sponsor-Investigators at Academic Health Centres–The Regulatory “Canaries in a Coal Mine” EK O’Reilly, MEB Holbein, JP Berglund, AB Parrish, MT Roth, BK Burnett Clinical and Investigative Medicine 36 (6), E290-E296, 2013 | 6 | 2013 |
| Via media: Role and responsibilities of the independent safety officer MEB Holbein, BN Hammack, AJ Melvin, TA Knox Journal of Clinical and Translational Science 3 (4), 147-151, 2019 | 1 | 2019 |
| Recommendations from the IND/IDE taskforce of the clinical and translational science award consortium: developing and implementing a sponsor-investigators training program MEB Holbein, JP Berglund, EK O'Reilly, K Hartman, LA Speicher, ... Journal of investigative medicine: the official publication of the American …, 2014 | 1 | 2014 |
| Cephalosporin confusion-one simple solution? MEB Holbein, VS Crane American Journal of Hospital Pharmacy 48 (2), 1991 | 1 | 1991 |
| Understanding food and drug administration (FDA) regulatory requirements for investigational new drug applications (IND) for sponsor-investigators MEB Holbein Clinical Research: From Proposal to Implementation, 132-146, 2012 | | 2012 |
